Lucknow Speciality Pharma

Decitabine Injection 50 mg
Decitabine is a nucleoside metabolic inhibitor indicated in order to treat patients with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). To get access, please contact Patient Support Team @ +91 9760014849 / 9555306364 / 9794360370 / 9140551027, Time 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) / WhatsApp for the same.
Get Access Price
WhatsApp

Decitabine Injection has EU approval for acute myeloid leukemia (AML).

The FDA approved the drug Decitabine in 2006.

Decitabine Injection Available Price In Lucknow Banaras Nepal

Decitabine Injection

  • Generic Brand Name – NATDECITA
  • Innovator Brand Name – Dacogen
  • API – Decitabine
  • Packaging – Single-Use Vial
  • Strength – 50mg
  • Manufacturer Name – Celon Labs

What is decitabine used for?

Decitabine Injection is a nucleoside metabolic inhibitor indicated in order to treat patients with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).

    About Us

    Lucknow Speciality Pharma is dedicated to delivering life-changing healthcare solutions. As a trusted wholesale supplier of specialized medicines, we cater to critical care areas such as oncology, nephrology, and rare diseases. Our patient-centric approach also includes personalized catering services, ensuring that patients receive the care, support, and nutrition they need to thrive. We also extend our services globally, welcoming international patients and buyers who seek our expertise and high-quality products.

    Lucknow Speciality Pharma is a registered Pharmaceutical Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices. 

    Get Access To Decitabine Injection 50 mg

    Enter Buying Requirements Details

    For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.

    Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Indore | Patna | Kolkata | Nepal

    FAQs – Medicine Questions

    Decitabine Injection 50 mg
    Is Decitabine an FDA-approved drug?
    The FDA approved the drug Decitabine in 2006.
    What are the alternate brands of Decitabine Injection?
    Xalibo Injection (Dr Reddy’S Laboratories Ltd)Decitex 50mg Injection (Sun Pharmaceutical Industries Ltd)Natdecita 50mg Injection (Natco Pharma Ltd)Decitas 50mg Injection (Intas Pharmaceuticals Ltd)Deczuba 50mg Injection (Glenmark Pharmaceuticals Ltd)Dacogen 50mg Injection (Johnson & Johnson Pvt Ltd)
    How does Decitabine work?
    As a hypomethylating agent, decitabine works in order to switch off a protein named DNA methyltransferase. This switches on the genes that block the cancerous cells growing as well as dividing.
    Where can I buy Decitabine injection?

    You can buy Decitabine injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

    The buyer should check the existing law in their home country before importing the product.

    What is the procedure to buy Decitabine?

    Patients can simply fill the order form or can send mail at info@lucknowpharma.com. Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Decitabine Injection price as well as procurement procedure.

    Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

    How to store Decitabine?
    Store the medicine at a temperature of 25°C (77°F).

    NEWS / UPDATES

    1. Janssen-Cilag International NV, Electronic medicines compendium (emc), [ Revised on March 2019] [ Accessed on 9th April], https://www.medicines.org.uk/emc/files/pil.2838.pdf
    2. Otsuka America Pharmaceutical, US Food and Drug Administration, [ Revised on December 2018] [ Accessed on 9th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021790s021lbl.pdf
    3. Michael Daskalakis et al; Decitabine; Recent Results in cancer Research 2010; Accessed 09/042021; https://pubmed.ncbi.nlm.nih.gov/20072836/